Insider Selling: Indivior (NASDAQ:INDV) CFO Sells 36,000 Shares of Stock

Indivior PLC (NASDAQ:INDV) CFO Ryan Preblick sold 36,000 shares of the company’s stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $37.70, for a total value of $1,357,200.00. Following the completion of the sale, the chief financial officer owned 284,751 shares of the company’s stock, valued at $10,735,112.70. This trade represents a 11.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Indivior Price Performance

INDV opened at $38.26 on Wednesday. The company has a market capitalization of $4.66 billion, a price-to-earnings ratio of 19.62 and a beta of 0.88. Indivior PLC has a 1-year low of $13.44 and a 1-year high of $41.00. The business has a 50 day moving average price of $34.94 and a two-hundred day moving average price of $34.19.

Indivior (NASDAQ:INDV) last released its earnings results on Tuesday, March 31st. The company reported $0.96 earnings per share for the quarter. The firm had revenue of $317.00 million during the quarter. Indivior had a negative return on equity of 219.26% and a net margin of 19.44%. Equities analysts expect that Indivior PLC will post 4.05 EPS for the current fiscal year.

Institutional Trading of Indivior

Large investors have recently added to or reduced their stakes in the company. Quarry LP acquired a new stake in Indivior during the 3rd quarter valued at $26,000. Raymond James Financial Inc. acquired a new stake in Indivior during the 2nd quarter valued at $26,000. Salomon & Ludwin LLC acquired a new stake in Indivior during the 4th quarter valued at $30,000. Harbor Capital Advisors Inc. raised its stake in Indivior by 309.9% during the 4th quarter. Harbor Capital Advisors Inc. now owns 1,033 shares of the company’s stock valued at $37,000 after purchasing an additional 781 shares during the period. Finally, Caitong International Asset Management Co. Ltd raised its stake in Indivior by 72.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,093 shares of the company’s stock valued at $39,000 after purchasing an additional 460 shares during the period. 60.33% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on INDV shares. Zacks Research upgraded Indivior from a “hold” rating to a “strong-buy” rating in a research report on Monday, March 16th. Weiss Ratings downgraded Indivior from a “hold (c+)” rating to a “hold (c)” rating in a research report on Wednesday, May 6th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, Indivior presently has a consensus rating of “Buy” and a consensus target price of $39.33.

Indivior Company Profile

Indivior plc is a specialty pharmaceutical company dedicated to developing and delivering treatments for addiction and related mental health disorders. The company’s portfolio centers on therapies designed to support individuals dealing with opioid dependence, alcohol use disorder and other behavioral health challenges. Its lead products include Suboxone® (buprenorphine and naloxone) sublingual film and Sublocade® (extended-release buprenorphine) injection, both of which are approved in multiple markets to aid in opioid use disorder management.

Indivior was established in 2014 through a demerger from the pharmaceuticals division of Reckitt Benckiser Group plc, inheriting decades of research and commercial expertise in addiction medicine.